Minimal clinically important rehabilitation effects in patients with osteoarthritis of the lower extremities

Journal of Rheumatology

Volumn 29, Issue 1, 2002, Pages 131-138

  Angst, F ^a   Aeschlimann, A ^a   Michel, B A ^a   Stucki, G ^a  

^a NONE   (Switzerland)

Author keywords

Biometry; Osteoarthritis; Rehabilitation; SF 36; Womac

Indexed keywords

ADULT; AGED; ARTICLE; BIOMETRY; FEMALE; FOLLOW UP; FUNCTIONAL ASSESSMENT; GERMANY; HUMAN; MAJOR CLINICAL STUDY; MALE; OSTEOARTHRITIS; OUTCOMES RESEARCH; PHYSICAL DISABILITY; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUALITY OF LIFE; QUESTIONNAIRE; RATING SCALE; SCORING SYSTEM; WESTERN ONTARIO AND MACMASTER UNIVERSITIES OSTEOARTHRITIS INDEX;

ADULT; AGED; AGED, 80 AND OVER; COHORT STUDIES; DISEASE PROGRESSION; FEMALE; HEALTH SURVEYS; HUMANS; LEG; MALE; MIDDLE AGED; OSTEOARTHRITIS; PATIENT SATISFACTION; PROSPECTIVE STUDIES; REGRESSION ANALYSIS; TREATMENT OUTCOME;

EID: 0036138928     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Therapeutic targets in osteoarthritis
2. Outcome measurement in osteoarthritis, clinical trials
3. Guidelines for testing slow acting drugs in osteoarthritis
4. Reproducibility and responsiveness of health status measures. Statistics and strategies for evaluation
5. Indexes of severity for osteoarthritis of the hip and knee
6. A preliminary evaluation of the dimensionality and clinical importance of pain and disability in osteoarthritis of the hip and knee
7. Validation study of WOMAC: A health status instrument for measuring clinically important patient relevant outcomes to antirheumatic drug therapy in patients with osteoarthritis of the hip or knee
8. Pain assessment in osteoarthritis: Experience with the WOMAC Osteoarthritis Index
9. Signal measurement strategies: Are they feasible and do they offer any advantage in outcome measurement in osteoarthritis?
10. Double blind randomized controlled trial of sodium meclofenamate (Meclomen) and diclofenac sodium (Voltaren): Post validation reapplication of the WOMAC Osteoarthritis Index
11. Evaluation of a German version of the WOMAC (Western Ontario and McMaster Universities) Osteoarthritis Index
12. Measurement of health status. Ascertaining the minimal clinically important difference
13. Comparison of a generic (SF-36) and a disease specific (WOMAC) instrument in the measurement of outcomes after knee replacement surgery
14. Methods for assessing condition-specific and generic functional status outcomes after total knee replacement
15. A comparison of different indices of responsiveness
16. Comparative responsiveness of 3 functional indices in ankylosing spondylitis
17. The effect of elective total hip replacement on health-related quality of life
18. Development of criteria for osteoarthritis
19. Relative responsiveness of condition-specific and generic health status measures in degenerative lumbar spinal stenosis
20. Measurement properties of a self-administered outcome measure in lumbar spinal stenosis
21. Assessing the clinical importance of symptomatic improvements. An illustration in rheumatology
22. Application of statistical graphics to facilitate selection of health status measures for clinical practice and evaluative research
23. Responsiveness and sensitivity to change of SLE disease activity measures
24. Minimal perceptible clinical improvement with the Western Ontario and McMaster Universities Osteoarthritis Index questionnaire and global assessments in patients with osteoarthritis
25. Determining minimally important changes in generic and disease-specific health-related quality of life questionnaires in clinical trials of rheumatoid arthritis
26. Effect sizes for interpreting changes in health status
27. Responsiveness and validity in health status measurement: A clarification
28. Optimistic biases about personal risk
29. Measuring health changes among severely ill patients. The floor phenomenon